• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人心室肌细胞早期后除极的模拟:这对心脏安全药理学有帮助吗?

Simulation of early after-depolarisation in non-failing human ventricular myocytes: can this help cardiac safety pharmacology?

机构信息

SCAP Test, rue d'Albroux, 10 - B-1367 Grand Rosière Hottomont, Belgium.

出版信息

Pharmacol Rep. 2013;65(5):1281-93. doi: 10.1016/s1734-1140(13)71486-5.

DOI:10.1016/s1734-1140(13)71486-5
PMID:24399724
Abstract

BACKGROUND

Identified as being the primary mechanism involved in the induction of torsades de pointes (TdP), early after-depolarisation (EAD) formation is an important parameter in cardiac safety pharmacology. Easily observed experimentally at the cellular or tissue level, EAD can also be simulated by computer algorithms using animal or human models. During the last decade, confidence in these algorithms has greatly increased. We investigated the putative usefulness of EAD simulation for cardiac safety pharmacology.

METHODS

EAD simulations were performed in non-failing human ventricular myocytes using the O'Hara-Rudy dynamic model. The role of each cardiac current was investigated by modifying the amplitude of its activity in the model. Prediction of EAD induction by drugs was based on the ratio of their 50% inhibitory concentration values for various cardiac ionic currents to their maximal effective free therapeutic plasma concentration (EFTPCmax).

RESULTS

In the ventricular endocardial myocytes, EAD was only induced by at least 85% inhibition of the rapid delayed rectifier K(+) current (IKr). The other currents can either induce or prevent EAD under sub- (80% IKr inhibition) or up-threshold conditions (87% IKr inhibition) of EAD. The study of the ability of drugs to induce EAD resulted in a classification which was in agreement with the Tdp risk classification.

CONCLUSION

Based on EAD computer simulation within the human situation, the present study identified the role of various cardiac currents in the EAD formation and suggested that prediction of EAD formation can be useful for early cardiac safety pharmacology.

摘要

背景

早期后除极(EAD)的形成被认为是导致尖端扭转型室性心动过速(TdP)的主要机制,它是心脏安全药理学中的一个重要参数。EAD 在细胞或组织水平上很容易通过实验观察到,也可以使用动物或人类模型通过计算机算法进行模拟。在过去十年中,人们对这些算法的信心大大增强。我们研究了 EAD 模拟在心脏安全药理学中的潜在用途。

方法

使用 O'Hara-Rudy 动力学模型在非衰竭的人心室肌细胞中进行 EAD 模拟。通过改变模型中各心脏电流的活动幅度来研究各心脏电流的作用。药物诱导 EAD 的预测基于其对各种心脏离子电流的 50%抑制浓度值与最大有效游离治疗血浆浓度(EFTPCmax)的比值。

结果

在心室内膜心肌细胞中,只有快速延迟整流钾电流(IKr)的抑制率至少达到 85%时才会诱发 EAD。在 EAD 亚阈值(IKr 抑制率 80%)或阈上条件(IKr 抑制率 87%)下,其他电流可诱发或预防 EAD。对药物诱导 EAD 的能力的研究导致了一种分类,该分类与 Tdp 风险分类一致。

结论

基于人类情况下的 EAD 计算机模拟,本研究确定了各种心脏电流在 EAD 形成中的作用,并表明 EAD 形成的预测可能对早期心脏安全药理学有用。

相似文献

1
Simulation of early after-depolarisation in non-failing human ventricular myocytes: can this help cardiac safety pharmacology?人心室肌细胞早期后除极的模拟:这对心脏安全药理学有帮助吗?
Pharmacol Rep. 2013;65(5):1281-93. doi: 10.1016/s1734-1140(13)71486-5.
2
Occurrence of early afterdepolarization under healthy or hypertrophic cardiomyopathy conditions in the human ventricular endocardial myocyte: In silico study using 109 torsadogenic or non-torsadogenic compounds.健康或肥厚型心肌病条件下人心室心内膜心肌细胞中早期后除极的发生:使用 109 种致扭转型或非致扭转型化合物的计算机模拟研究。
Toxicol Appl Pharmacol. 2022 Mar 1;438:115914. doi: 10.1016/j.taap.2022.115914. Epub 2022 Feb 10.
3
Impact of disease state on arrhythmic event detection by action potential modelling in cardiac safety pharmacology.疾病状态对心脏安全药理学中通过动作电位建模检测心律失常事件的影响。
J Pharmacol Toxicol Methods. 2019 Mar-Apr;96:15-26. doi: 10.1016/j.vascn.2018.12.004. Epub 2018 Dec 21.
4
Dynamical mechanisms of phase-2 early afterdepolarizations in human ventricular myocytes: insights from bifurcation analyses of two mathematical models.人心室肌细胞中2相早期后去极化的动力学机制:来自两个数学模型分岔分析的见解
Am J Physiol Heart Circ Physiol. 2017 Jan 1;312(1):H106-H127. doi: 10.1152/ajpheart.00115.2016. Epub 2016 Nov 11.
5
Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.豚鼠心肌细胞与克隆的人乙醚-去极化相关基因(hERG,I(Kr))通道的比较药理学
J Cardiovasc Electrophysiol. 2004 Nov;15(11):1302-9. doi: 10.1046/j.1540-8167.2004.04099.x.
6
Optimization of an Cardiac Cell Model for Proarrhythmia Risk Assessment.用于心律失常风险评估的心脏细胞模型的优化
Front Physiol. 2017 Aug 23;8:616. doi: 10.3389/fphys.2017.00616. eCollection 2017.
7
A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).一种新的生物标志物——心脏电生理平衡指数(iCEB)——在药物诱发的心律失常中发挥着重要作用:超越QT间期延长和尖端扭转型室性心动过速(TdP)。
J Pharmacol Toxicol Methods. 2013 Sep-Oct;68(2):250-259. doi: 10.1016/j.vascn.2013.01.003. Epub 2013 Jan 19.
8
Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.人诱导多能干细胞衍生心肌细胞在评估药物致 QT 间期延长潜力中的应用。
Toxicol Appl Pharmacol. 2014 Jul 1;278(1):72-7. doi: 10.1016/j.taap.2014.04.007. Epub 2014 Apr 15.
9
Significance of integrated in silico transmural ventricular wedge preparation models of human non-failing and failing hearts for safety evaluation of drug candidates.整合的人类非衰竭和衰竭心脏的计算机模拟跨壁心室楔形制备模型在候选药物安全性评估中的意义。
J Pharmacol Toxicol Methods. 2017 Jan-Feb;83:30-41. doi: 10.1016/j.vascn.2016.08.007. Epub 2016 Aug 18.
10
Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform.使用Maestro MEA平台对人诱导多能干细胞衍生心肌细胞进行心律失常风险评估。
Toxicol Sci. 2015 Sep;147(1):286-95. doi: 10.1093/toxsci/kfv128. Epub 2015 Jun 27.

引用本文的文献

1
The importance of mechanical conditions in the testing of excitation abnormalities in a population of electro-mechanical models of human ventricular cardiomyocytes.机械条件在一群人心室心肌细胞的机电模型中激发异常测试中的重要性。
Front Physiol. 2023 Jun 8;14:1187956. doi: 10.3389/fphys.2023.1187956. eCollection 2023.
2
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy.用于验证致心律失常风险预测模型的一般原则:CiPA 计算机模拟策略的扩展。
Clin Pharmacol Ther. 2020 Jan;107(1):102-111. doi: 10.1002/cpt.1647. Epub 2019 Nov 10.
3
Global Sensitivity Analysis of Ventricular Myocyte Model-Derived Metrics for Proarrhythmic Risk Assessment.
用于心律失常风险评估的心室肌细胞模型衍生指标的全局敏感性分析
Front Pharmacol. 2019 Oct 2;10:1054. doi: 10.3389/fphar.2019.01054. eCollection 2019.
4
Early afterdepolarisation tendency as a simulated pro-arrhythmic risk indicator.早期后除极倾向作为一种模拟的致心律失常风险指标。
Toxicol Res (Camb). 2017 Nov 1;6(6):912-921. doi: 10.1039/c7tx00141j. Epub 2017 Sep 14.
5
Novel Two-Step Classifier for Torsades de Pointes Risk Stratification from Direct Features.基于直接特征的用于尖端扭转型室性心动过速风险分层的新型两步分类器
Front Pharmacol. 2017 Nov 14;8:816. doi: 10.3389/fphar.2017.00816. eCollection 2017.
6
Identification of Na+/K+-ATPase inhibition-independent proarrhythmic ionic mechanisms of cardiac glycosides.鉴定强心苷非钠/钾-ATP 酶抑制相关的致心律失常离子机制。
Sci Rep. 2017 May 26;7(1):2465. doi: 10.1038/s41598-017-02496-4.
7
Evolution of strategies to improve preclinical cardiac safety testing.改善临床前心脏安全性测试策略的演变。
Nat Rev Drug Discov. 2016 Jul;15(7):457-71. doi: 10.1038/nrd.2015.34. Epub 2016 Feb 19.
8
Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block.人诱导多能干细胞衍生的心肌细胞与成人心肌细胞:关于离子电流阻断效应的计算机电生理研究
Br J Pharmacol. 2015 Nov;172(21):5147-60. doi: 10.1111/bph.13282. Epub 2015 Oct 15.